Regulation - Votrient

Filter

Current filters:

Votrient

Popular Filters

GlaxoSmithKline files for expanded use for Votrient

07-08-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) says it has submitted a request to the European Medicines…

EuropeGlaxoSmithKlineOncologyPharmaceuticalRegulationVotrient

EMA approves GlaxoSmithKline's Votrient for soft tissue sarcomas

09-08-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) says that the European Medicines Agency has approved Votrient…

EuropeGlaxoSmithKlineOncologyPharmaceuticalRegulationVotrient

US FDA backs new indications for Votrient and Afinitor

29-04-2012

The US Food and Drug Administration last week gave its approval for new indications for currently marketed…

AfinitorGlaxoSmithKlineNorth AmericaNovartisOncologyPharmaceuticalRegulationVotrient

FDA panel backs GlaxoSmithKline sarcoma drug Votrient

21-03-2012

Providing welcome news for UK pharma giant GlaxoSmithKline (LSE: GSK), the Oncologic Drugs Advisory Committee…

GlaxoSmithKlineNorth AmericaOncologyPharmaceuticalRegulationVotrient

New Zealand to fund new cancer drugs Tykerb and Votrient

05-03-2012

The Pharmaceutical Management Agency of New Zealand, PHARMAC, says it is funding two new targeted cancer…

Asia-PacificGlaxoSmithKlineOncologyPharmaceuticalPricingRegulationTykerbVotrient

Back to top